U.S. needs better way to track drug safety - study
Staff walk among the new buildings at the the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland, November 5, 2009.
WASHINGTON (Reuters) - The U.S. Food and Drug Administration should review drugs on a regular basis for as long as they are on the market in order to catch any new safety issues, according to a report from an independent research body.
Credit: Reuters/Jason Reed
Anna Yukhananov
WASHINGTON
Tue May 1, 2012 1:11pm EDT
link-
http://www.reuters.com/article/2012/05/01/us-fda-iom-safety-idUSBRE84015420120501